What Triplex International Biosciences does

Triplex International Biosciences (China) Co., Ltd. (TIB) is a privately-held in vitro diagnostics (IVD) manufacturer founded in 2004 and headquartered in Xiamen, Fujian, China. The company develops, manufactures, and distributes diagnostic products across three core technology platforms: immunological diagnostics (colloidal gold immunochromatography and rapid test kits), molecular diagnostics (real-time fluorescent PCR and RT-PCR fluorescence probing methods), and pathological diagnostics (liquid-based cytology, automated staining, and AI-aided cervical screening). Its 48-product portfolio spans infectious disease testing (SARS-CoV-2, influenza, malaria, dengue, cholera, HIV, HBV, HCV, tuberculosis, monkeypox, GBS, HSV, CT, NG, UU), women's health screening (HPV 23-subtype genotyping kits and cervical cancer screening solutions), supporting instruments (TIB-NA3200 extractor, TIB-8600 qPCR, Auto3000/Auto9600 hybridization, AutoPrep LBC processors), and an emerging AI-augmented cytology screening solution.

The company operates a B2B go-to-market targeting clinical laboratories, hospitals, and qualified distributors globally, with revenue generated from one-time reagent sales and instrument hardware sales. Distribution is conducted through direct inquiry (website, WhatsApp, email), free sample-evaluation programs for qualified buyers, and active participation in flagship trade exhibitions including MEDICA (Düsseldorf), CMEF (Shanghai), and CACLP (Nanchang). Manufacturing takes place at an integrated 70,000 m² campus with in-house quality control, ISO 13485 compliance, CE-marked products, and over 20 NMPA medical device registration certificates. R&D is supported by three independent research centers in Xiamen, Beijing, and Fuzhou, and joint laboratories with Peking University, Xiamen University, Yale, Columbia, Taipei University of Science and Technology, and the Second Military Medical University. Pricing is quote-based and not publicly disclosed.

Name

Triplex International Biosciences

Legal name

Triplex International Biosciences (China) Co.,LTD

Website

https://triplexbio.com

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

101–250 employees

Short description

Triplex International Biosciences is a Chinese IVD manufacturer founded in 2004, producing molecular, immunological, and pathological diagnostic kits and supporting instruments for clinical laboratories, hospitals, and distributors globally from its Xiamen headquarters.

Ownership category

akta.pro rank

Product category

In Vitro Diagnostics (IVD)

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)

akta.pro primary industry

IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM)

akta.pro secondary industries

Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels) (HLAAALAC), Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

Keywords

• In vitro diagnostics
• Molecular diagnostic kits
• Rapid test kits
• Liquid-based cytology
• Immunodiagnostic reagents

Headquarters

HQ city

Xiamen

HQ country

China

HQ region

Asia

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Operations, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. IVD Reagent Sales: The company generates revenue primarily through the sale of immunodiagnostic reagents, molecular diagnostic reagents, and pathological diagnostic reagents including rapid test kits, PCR detection kits, staining solutions, and liquid-based cytology products.
2. Supporting Instruments and Equipment: Sale of automated instruments including nucleic acid extractors (TIB-NA3200), PCR instruments (TIB-8600), hybridization instruments (Auto3000, Auto9600), and liquid-based cytology processors (TIB-AutoPrep series).

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Triplex International Biosciences (TIB) manufactures and globally distributes in vitro diagnostic (IVD) reagent kits and supporting laboratory instruments across three proprietary technology platforms — Immunological (colloidal gold rapid tests), Molecular (real-time fluorescent PCR kits and nucleic acid extraction), and Pathological (liquid-based cytology systems and AI-aided cervical screening). The product range covers infectious disease detection (SARS-CoV-2, HIV, HPV, HBV, HCV, GBS, influenza, dengue, malaria, cholera, tuberculosis), sexually transmitted infections, and women's health screening, paired with automated instruments such as the TIB-NA3200 extractor, TIB-8600 qPCR, and AutoPrep cytology processors. Sales are conducted B2B to clinical laboratories, hospitals, and qualified distributors with free sample evaluation programs.

Product overview

Triplex International Biosciences (TIB) is an IVD manufacturer established in 2004 offering a comprehensive portfolio of diagnostic products organized across four main technology platforms: Molecular Diagnosis Solutions (27 products including PCR instruments, extraction systems, and nucleic acid detection kits for pathogens like HPV, HBV, HCV, GBS, SARS-CoV-2, and other infectious agents), Immunologic Diagnosis Solutions (rapid test kits for HIV, Dengue, Malaria, Cholera, Flu, and SARS-CoV-2 using colloidal gold and immunochromatographic methods), Pathological Diagnostic Solutions (liquid-based cytology instruments TIB-AutoPrep series, LBC cytocentrifuge, staining kits, and AI-aided cervical cancer screening solution), and SARS-CoV-2 Detection Kit Series (6 dedicated products including antigen, antibody, neutralizing antibody, and combo rapid tests plus nucleic acid detection). The product ecosystem integrates instruments (TIB-NA3200 extractor, TIB-8600 qPCR, Auto3000/Auto9600 hybridization instruments, AutoPrep processors) with compatible diagnostic kits to provide end-to-end solutions for clinical diagnostics, with specific focus on women's health (cervical cancer screening, HPV, GBS), infectious disease detection, and molecular/immunological/pathological testing for laboratory and point-of-care use.

Differentiator

Problem solved

Functional benefit

Products and services

• Automatic Nucleic Acid Extractor (TIB-NA3200) Automated nucleic acid extraction instrument using magnetic bead-based technology with 32-sample throughput, temperature control, and UV disinfection. Supports DNA and RNA extraction with over 50 compatible extraction kits; designed for clinical and research laboratories performing molecular diagnostics.
• Automatic Nucleic Acid Hybridization Instrument (Auto9600) Full-automatic nucleic acid hybridization instrument with 96 samples per batch capacity, microcomputer control, high-precision temperature control, and UV disinfection. Processes HPV 23 Subtypes Genotyping Kit and other hybridization assays for clinical laboratories.
• Automatic Nucleic Acid Hybridization Instrument (Auto3000) Automatic nucleic acid hybridization instrument with 20 samples per batch, precision temperature control, and ready-to-use reagents; designed for clinical molecular diagnostics laboratories.
• TIB-8600 Real-time Fluorescent Quantitative PCR Instrument Real-time fluorescent qPCR instrument with 6 detection channels, accurate temperature control system, global leading optical detection, and wide wavelength range (400nm-700nm) for molecular diagnostic workflows in clinical and research laboratories.
• SARS-CoV-2 Nucleic Acid Detection Kit (RT-PCR Fluorescence Probing Method) RT-PCR fluorescence probing kit for SARS-CoV-2 detection with high sensitivity, internal standard monitoring, and 48 tests/kit packaging. CE marked, intended for clinical laboratories and testing centers.
• SARS-CoV-2 Antigen Rapid Test Kit Rapid in vitro qualitative detection of SARS-CoV-2 nucleocapsid protein antigen. Sensitivity 98.51%, specificity 99.91%, results in 15 minutes. Holds more than 20 medical product registration certificates including NMPA; intended for clinical and point-of-care use.
• SARS-CoV-2 & Flu A+B Antigen Combo Rapid Test Kit Combined colloidal gold rapid test for simultaneous detection of SARS-CoV-2, influenza A and B nucleoprotein antigens from nasopharyngeal/oral swabs or saliva. CE marked, designed for clinical and point-of-care settings.
• SARS-CoV-2 IgM/IgG Rapid Test Kit Rapid qualitative detection of SARS-CoV-2 IgG and IgM antibodies in whole blood, serum, or plasma for supplementary clinical detection. CE marked, intended for use in clinical settings.
• SARS-CoV-2 Neutralizing Antibody Rapid Test Kit (Colloidal Gold) Rapid qualitative assessment of SARS-CoV-2 neutralizing antibody in human serum, plasma, or whole blood using colloidal gold immunoassay. Results in 15-20 minutes; CE marked for clinical use.
• SARS-CoV-2 Neutralizing Antibody Rapid Test Kit (TRFIA) Time-Resolved Fluoroimmunoassay (TRFIA) kit for SARS-CoV-2 neutralizing antibody detection to evaluate vaccine efficacy. CE marked, intended for clinical laboratories.
• HPV Types 16 and 18 DNA Diagnostic Kit Real-time PCR kit for qualitative detection of HPV 16 and 18 nucleic acid in cervical samples. Lower limit of quantitation of 1.0×10^3 copies/mL. CE marked, ISO 13485 certified; intended for cervical cancer screening in clinical laboratories.
• HPV 23 Subtypes DNA Diagnostic Kit PCR-RDB (reverse dot blot hybridization) kit for detection of 23 HPV subtypes including high and low risk types. Designed for cervical cancer screening and HPV genotyping in clinical laboratories.
• GBS (Group B Streptococcus) DNA Diagnostic Kit Real-time fluorescence PCR kit for GBS DNA detection in genital tract/rectum secretions. First NMPA-approved GBS PCR kit in China; used for prenatal/neonatal care to prevent neonatal sepsis, meningitis, and pneumonia.
• HBV (Hepatitis B Virus) DNA Quantitative Diagnostic Kit PCR probe fluorescence kit for quantitative detection of HBV-DNA with high sensitivity and accuracy for clinical diagnosis and therapeutic monitoring of hepatitis B. Intended for clinical laboratories.
• HCV (Hepatitis C Virus) RNA Genotyping Kit Real-time PCR kit for genotyping HCV 1b, 2a, 3a, 3b and 6a types. Guides therapeutic schedule and monitors treatment effect; intended for clinical hepatitis C diagnostics.
• Mycobacterium Tuberculosis Nucleic Acid Detection Kit Fluorescent PCR kit for Mycobacterium tuberculosis detection in sputum, hydrothorax, and cerebrospinal fluid samples. High sensitivity and specificity, 48 tests/kit; for clinical tuberculosis diagnostics.
• Monkeypox Virus Nucleic Acid Detection Kit In vitro qualitative detection of monkeypox virus DNA in blood, wound, or pus samples. Limit of detection 500 copies/mL; PCR fluorescence probing method, 48 tests/kit; for clinical diagnostics.
• HSV-Ⅰ (Herpes Simplex Virus Ⅰ) DNA Diagnostic Kit DNA diagnostic kit for HSV-Ⅰ (oral herpes) detection with excellent DNA extraction effect, 24 tests/kit. Intended for clinical sexually transmitted infection diagnostics.
• HIV Ag/Ab Rapid Test Kit (4th Generation) 4th generation point-of-care test for simultaneous detection of HIV-1/HIV-2 antibodies and HIV-1 p24 antigen using sandwich-based immunolateral chromatography. Detects acute infections earlier than 2nd and 3rd generation tests; sensitivity 100%, specificity 100%, results in 15 minutes. Room-temperature stable, 12-month shelf life.
• Dengue NS1 Antigen Rapid Test Kit Colloidal gold double antibody sandwich immunoassay for Dengue NS1 antigen in whole blood, serum, or plasma. Sensitivity 98.63%, specificity 99.66%, 24-month shelf life, CE marked; for clinical dengue diagnosis and screening.
• Malaria Antigen P.f/Pan Rapid Test Kit Rapid qualitative differential test for HRP-Ⅱ (P.falciparum) and pLDH (P.v, P.m, P.o) malaria antigens in whole blood. Results within 15 minutes; intended for clinical malaria diagnostics in endemic regions.
• Flu A & B Rapid Test Kit Rapid qualitative detection of influenza A and B nucleoprotein antigens in nasopharyngeal, nasal, oropharyngeal swabs or saliva. 15-20 minutes, room temperature storage; for clinical influenza diagnosis.
• Cholera Antigen O1/O139 Rapid Test Kit Rapid qualitative detection of Vibrio cholera O1/O139 in human fecal specimens. Intended for clinical cholera diagnostics and outbreak screening.
• Artificial Intelligence-aided Cervical Cytological Screening Solution AI-powered cervical cancer screening solution integrating standardized staining, high-definition digital scanning, and artificial intelligence diagnosis based on big data. Provides whole-process quality control and department digitalization for clinical pathology laboratories and cervical screening programs.
• LBC Cytocentrifuge Liquid-based thin-layer cell preparation system using membrane filtration and specific gravity centrifugation. Prepares 1-40 slides in 3 minutes, with 16 or 40 throughput options; for clinical cytology laboratories.
• Liquid-based Cytology (TIB-AutoPrep 2406 Processor) Automated liquid-based cytology processor using natural sedimentation technology for cervical sample preparation; intended for clinical pathology laboratories.
• Liquid-based Cytology (TIB-AutoPrep 4806 Processor) Automated liquid-based cytology processor with advanced natural sedimentation and full-automatic staining technology; for clinical cytology and cervical cancer screening workflows.
• Thin-layer Cytology Test (TIB AutoPrep-1000 Processor) Thin-layer cytology preparation system using physical pumping and precise filter techniques to transfer cells onto slides; for clinical pathology and cytology laboratories.

Quantifiable outcome

• 98.63% sensitivity and 99.66% specificity for Dengue NS1 Antigen Rapid Test Kit
• +3 more outcomes

Named customers4 records

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature7 records

Partnerships

Eight partnerships are on record, tiered core and major.

• Peking University Medical CentercoreStrategic or Co-development PartnerEstablished TIB–Peking University Laboratory of Molecular Pathology for joint research and development in molecular diagnostics.
• Xiamen UniversitycoreStrategic or Co-development PartnerEstablished School of Life Sciences–TIB Biomedical Diagnostic Research and Development Center for collaborative diagnostic product development.
• Shanghai Oriental Hepatic-Hospital of the Second Military Medical UniversitycoreStrategic or Co-development PartnerJoint establishment of Fujian Provincial Key Laboratory of Joint Hepatobiliary Technology Innovation, led by Academician Wu Mengchao.
• Mengchao Hepatobiliary Hospital of Fujian Medical UniversitycoreStrategic or Co-development PartnerCollaborative partner in hepatobiliary technology innovation laboratory alongside Shanghai Oriental Hepatic-Hospital.
• Yale UniversitymajorStrategic or Co-development PartnerInternational research partnership with Yale University for biomedical diagnostic research.
• Columbia UniversitymajorStrategic or Co-development PartnerInternational research partnership with Columbia University for biomedical diagnostic research.
• Taipei University of Science and TechnologymajorStrategic or Co-development PartnerInternational research partnership with Taipei University of Science and Technology for diagnostic technology development.
• Fujian–Taiwan Medical Instrument Technology Cooperation BasecoreStrategic or Co-development PartnerEstablished cooperation platform for Fujian-Taiwan medical instrument technology collaboration.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Cepheid (Danaher): Cepheid operates the GeneXpert molecular diagnostic platform widely used in hospital labs globally — overlapping with Triplex's molecular PCR business but at a much larger installed base and broader test menu.
• Hologic: Hologic is a global women's health diagnostics leader with the ThinPrep liquid-based cytology system, Panther molecular platform, and HPV test menu — the dominant global competitor to Triplex's cervical cancer screening (HPV + LBC + AI) franchise.
• Qiagen: Qiagen is a global molecular diagnostics and sample-preparation company with PCR kits, extraction reagents, and HPV/STI test menus — comparable to Triplex's nucleic acid extraction kits and molecular diagnostic reagents.
• BGI Genomics: BGI is a large Chinese genomics and molecular diagnostics company with broad infectious disease, reproductive health, and oncology test menus plus global lab services — a much larger incumbent with overlapping IVD product lines to Triplex.
• Roche Diagnostics: Roche operates the cobas family of automated PCR and immunoassay platforms with deep infectious disease and women's health test menus — the global market leader against which Triplex's mid-scale IVD offering competes for clinical lab tenders.
• Abbott Diagnostics: Abbott is a global IVD leader with the m2000 and Alinity molecular platforms plus rapid antigen tests — a broad incumbent with overlapping infectious disease and immunoassay products to Triplex's portfolio.

Direct peers

• Daan Gene (Kingmed Diagnostics group): Daan Gene is a major Chinese IVD manufacturer of PCR kits and automated molecular diagnostic instruments, with overlapping product lines in HPV, HBV, HCV, and infectious disease molecular testing — a direct peer to Triplex's molecular diagnostics portfolio.
• Sansure Biotech: Sansure is a Chinese molecular diagnostics company focused on nucleic acid diagnostic kits (including infectious disease panels) and automated extraction/PCR instruments — directly comparable to Triplex's molecular and instrument portfolio and serving similar clinical lab and hospital customers in China and globally.
• Autobio Diagnostics: Autobio is a leading Chinese IVD company producing immunoassay, microbiology, and clinical chemistry diagnostic kits and instruments for hospital and clinical lab customers — directly comparable to Triplex's immunologic and broader IVD reagent business.

Emerging players

• KingMed Diagnostics: KingMed is a major Chinese independent medical laboratory chain with significant HPV, infectious disease, and pathology testing volume — comparable to Triplex as it both operates testing services (per Triplex's own 'medical testing laboratories' mention) and consumes IVD reagents at scale.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/tibchina

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Triplex International Biosciences